Preclinical Cro services in
Non-rodent Studies
Streamline preclinical drug development with Gubra’s minipig CRO platform, including pharmacokinetics, metabolic studies, next-generation sequencing analysis and bioinformatics. Minipigs show close resemblance to human physiology, being ideal for translational studies. Our minipig studies provide good predictions of drug pharmacokinetic properties and adverse effects in humans.
Why choose Gubra for your non-rodent studies?
- 10+ years of experience in conducting minipig studies
- Environmentally controlled minipig facilities
- Full-service global partner in preclinical drug development
- Individually tailored study design to meet your research objectives
- Expert management of compound preparation and exposure analysis


Consult with Niels Vrang
Co-founder, Chief Science Officer
Advance your drug development with Gubra’s preclinical mini pig models
Advanced Preclinical Drug Development with Translational Mini Pig Models
Gubra offers miniature pig models applicable in both early and late-stage preclinical drug development, featuring high translational value for clinical study design. We integrate state-of-the-art PK analyses, NGS, and bioinformatics in a standard operating procedure (SOP) controlled environment to deliver regulatory-compliant solutions and data packages. Minipigs, with human-like anatomical and physiological traits, are ideal for drug PK studies. Our facility is approved by the Danish Experimental Inspectorate and monitored by our Animal Welfare Body.
Main Offerings
Instant availability of
Göttingen Minipigs
Advanced
RNA sequencing
Biochemical
assesment of plasma
Profile your preclinical drug candidate
Mini pig model

PK studies
- Ideal for both early- and late-stage preclinical studies
- Suitable for both short- and long-term drug treatment studies
- Comprehensive drug metabolite identification to track biotransformation
- Detailed exposure analysis to assess drug concentration over time
Explore our data
Download the Latest Posters
Check out our posters and discover why minipigs represent a suitable non-rodent
species for clinical translation of peptide drug pharmacokinetics.
Progress your study with greater certainty
Utilizing 3D Whole Organ Imaging in Non-Rodent Studies
Explore the full potential of 3D whole organ imaging with Gubra’s specialized services for non-rodent studies. Our high-throughput 3D light sheet imaging provides unparalleled insights into drug targets’ tissue distribution, biodistribution, and pharmaceutical modes of action. We offer comprehensive support from study design through data interpretation, utilizing advanced techniques such as high-resolution imaging, multiplexed antibody staining, and AI-enhanced analysis to deliver precise and actionable results.

Related pages
For further information
Contact us
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Denmark
+45 3152 2650








